Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Enzymatica publ AB (ENZY)

Stockholm
Currency in SEK
1.700
+0.070(+4.29%)
Closed
ENZY Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Trading near 52-week Low
Fair Value
Day's Range
1.5701.700
52 wk Range
1.5704.135
Key Statistics
Edit
Prev. Close
1.7
Open
1.63
Day's Range
1.57-1.7
52 wk Range
1.57-4.135
Volume
69.63K
Average Volume (3m)
111.62K
1-Year Change
-58.02%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ENZY Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Enzymatica publ AB Company Profile

Enzymatica AB (publ), a life science company, develops and sells products that treat and alleviate infections and symptoms in the upper respiratory tract. The company’s product includes ColdZyme, a mouth spray to treat and alleviate cold and flu symptoms. It also provides enzyme formulations for skin care. The company offers its products through contract organizations and partner agreements with distributors who sell the products under the ViruProtect, STADAProtect, and Bisolviral brand names. Enzymatica AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

Employees
18
Market
Sweden

Compare ENZY to Peers and Sector

Metrics to compare
ENZY
Peers
Sector
Relationship
P/E Ratio
−6.5x−4.8x−0.7x
PEG Ratio
−0.56−0.110.00
Price/Book
1.9x4.4x2.6x
Price / LTM Sales
7.9x14.2x3.2x
Upside (Analyst Target)
90.5%57.3%44.1%
Fair Value Upside
Unlock−7.5%8.2%Unlock

FAQ

What Is the Enzymatica publ AB (ENZY) Stock Price Today?

The Enzymatica publ AB stock price today is 1.70

What Stock Exchange Does Enzymatica publ AB Trade On?

Enzymatica publ AB is listed and trades on the Stockholm stock exchange.

What Is the Stock Symbol for Enzymatica publ AB?

The stock symbol for Enzymatica publ AB is "ENZY."

What Is the Enzymatica publ AB Market Cap?

As of today, Enzymatica publ AB market cap is 366.81M.

What is Enzymatica publ AB Earnings Per Share?

The Enzymatica publ AB EPS is -0.312.

What Is the Next Enzymatica publ AB Earnings Date?

Enzymatica publ AB will release its next earnings report on Feb 18, 2025.

From a Technical Analysis Perspective, Is ENZY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.